Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Rh Blood Group01:19

Rh Blood Group

4.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.6K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

71
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
71
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
6.2K
Diphtheria01:28

Diphtheria

146
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
146
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

991
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
991

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same author

Vitamin A and body weight status do not impact humoral immunity against measles, mumps or rubella in individuals 4 to 18 years old: a cross-sectional cohort study in India.

Vaccine·2026
Same author

Cytomegalovirus serostatus and plasma MCP-1 levels are associated with antibody response to seasonal influenza vaccine across age and sex.

medRxiv : the preprint server for health sciences·2026
Same author

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine.

Vaccine·2026
Same author

Seroprevalence of mumps and rubella antibodies among Indian children: evidence of a mumps immunity gap.

Vaccine·2026
Same author

COVID-19 vaccine policy: a response and way forward.

Vaccine·2026

関連する実験動画

Updated: Apr 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K

ルーベッラ・ルベッラ (ルベッラ・ルベッラ) とは

Nathaniel Lambert1, Peter Strebel2, Walter Orenstein3

  • 1Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.

Lancet (London, England)
|January 12, 2015
PubMed
まとめ
この要約は機械生成です。

ルーベッラウイルスは,先天性ルーベッラ症候群を引き起こす世界的な脅威であり続けています. ルーベッラワクチン接種プログラムはコントロールの鍵ですが,遺伝的要因はワクチンに対する免疫反応に影響します.

さらに関連する動画

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.6K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.6K

関連する実験動画

Last Updated: Apr 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K
Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.6K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.6K

科学分野:

  • 免疫学 免疫学とは
  • ワクチン学 ワクチン学
  • 公衆衛生は公衆衛生である.

背景:

  • ルーベッラウイルスは,毎年約10万例の先天性ルーベッラ症候群の症例が推定され,世界的な健康リスクとして引き続き存在しています.
  • ルベッラを含むワクチンは非常に効果的ですが,不完全なワクチン接種プログラムは,最近のアウトブレイクで強調されているように,進行中の病気の伝播に貢献しています.

研究 の 目的:

  • ルベッラ対策,排除,根絶戦略の見直しをすること.
  • ルベッラに対する新しい検査診断方法を提示する.
  • ルベッラを含むワクチンの免疫遺伝学と個々の免疫応答の多様性を調査する.

主な方法:

  • ルベッラ対策方針と検査室診断の見直し
  • ルベッラを含むワクチンに関連する免疫遺伝子のデータの分析.
  • 免疫応答の個体間変動性の調査.

主要な成果:

  • 2009年以来,アメリカ大陸では風土性赤血球の伝播が排除されています.
  • 不完全なワクチン接種は,世界中で赤血球の流行が続くことにつながります.
  • 新興の証拠は,遺伝的変異 (ハプロタイプ,SNP) を,赤血球ワクチンに対する免疫反応と関連付けています.

結論:

  • ルーベッラワクチン接種は,病気の制御と撲滅に不可欠です.
  • ワクチンの免疫遺伝学を理解することは,赤血球ワクチンの有効性を最適化するために不可欠です.
  • 遺伝的関連性に関するさらなる研究は,個別化されたワクチン接種戦略に情報を与えることができます.